BV6 is a small molecule antagonist of cellular IAP1 (c-IAP1) and X-linked IAP (XIAP), key members of the inhibitor of apoptosis protein family. It is widely used in biochemical and cellular research to study apoptosis regulation and has been employed in both in vitro and in vivo models to investigate cancer therapy and IAP function.